Cohen Veterans Bioscience
1 Broadway 14th Floor
4 articles with Cohen Veterans Bioscience
Brain research and advocacy non-profit Cohen Veterans Bioscience (CVB) announced today that it joined the PRISM 2 consortium as as a designated associated partner of the Innovative Medicines Initiative (IMI).
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
New Study Reveals Brain Circuit Biomarkers to Predict Response to Treatment in Patients with Complex Neuropsychiatric Disorders
- A new connectome-based diagnosis solution may help identify patient subtypes that best respond to therapy in individuals with post-traumatic stress disorder or major depressive disorder -
Cohen Veterans Bioscience Launches New Veterans Advisory Council (VAC) To Address Brain Health Priorities
VAC Unveils Initial Agenda for More Effective Treatment of Active Service Members & Veterans with Brain Trauma